Close

Aptose Biosciences (APTO) PT Raised to $9 at H.C. Wainwright

February 6, 2020 8:50 AM EST Send to a Friend
H.C. Wainwright analyst Joseph Pantginis raised the price target on Aptose Biosciences (NASDAQ: APTO) to $9.00 (from $6.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login